Methionine AminoPeptidase Type-2 Inhibitors Targeting Angiogenesis.
Ehlers T, Furness S, Robinson TP, Zhong HA, Goldsmith D, Aribser J, Bowen JP.
Curr Top Med Chem · review; journal article · DOI 10.2174/1568026615666150915121204 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för O-(chloroacetylcarbamoyl)fumagillol. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
11 träffarAdvanced Chemoembolization by Anti-angiogenic Calcium-Phosphate Ceramic Microspheres Targeting the Vascular Heterogeneity of Cancer Xenografts.
Emoto M, Yoshihisa H, Yano K, Choijamts B, Tsugu H, Tachibana K, Aizawa M.
Anticancer Res · research support, non-u.s. gov't; journal articleCheaper faster drug development validated by the repositioning of drugs against neglected tropical diseases.
Williams K, Bilsland E, Sparkes A, Aubrey W, Young M, Soldatova LN, De Grave K, Ramon J, de Clare M, Sirawaraporn W, Oliver SG, King RD.
J R Soc Interface · research support, non-u.s. gov't; research-article; journal article · DOI 10.1098/rsif.2014.1289The angiogenic inhibitor TNP-470 decreases caloric intake and weight gain in high-fat fed mice.
White HM, Acton AJ, Considine RV.
Obesity (Silver Spring) · research-article; journal article; research support, n.i.h., extramural · DOI 10.1038/oby.2012.87An angiogenesis inhibitor TNP-470 (AGM-1470) suppresses vascular smooth muscle cell proliferation in experimental rat aortotomy models.
Ogata T, Kurabayashi M, Maeno T, Maeno Y, Ishikawa S, Takeyoshi I, Morishita Y, Nagai R.
J Cardiovasc Surg (Torino) · comparative study; journal articleFrequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
Inoue K, Chikazawa M, Fukata S, Yoshikawa C, Shuin T.
Clin Cancer Res · journal articleEffect of TNP-470 (AGM-1470) on the growth of rat rhabdomyosarcoma tumors of different sizes.
Landuyt W, Theys J, Nuyts S, Drijkoningen M, Fowler J, Reijnders A, Liekens S, Neyts J, de Bruijn E, Anné J, Lambin P.
Cancer Invest · research support, non-u.s. gov't; journal article · DOI 10.1081/cnv-100000073Primary study in experimental antiangiogenic therapy of nasopharyngeal carcinoma with AGM-1470 (TNP-470).
Qian CN, Min HQ, Lin HL, Hong MH, Ye YL.
J Laryngol Otol · journal article · DOI 10.1017/s0022215100141878TNP-470 (AGM-1470): mechanisms of action and early clinical development.
Castronovo V, Belotti D.
Eur J Cancer · review; journal article · DOI 10.1016/s0959-8049(96)00388-7The angiogenesis inhibitor TNP-470 (AGM-1470) improves long-term survival of rats with liver metastasis.
Ahmed MH, Konno H, Nahar L, Tanaka T, Naito Y, Nakamura S, Baba S.
J Surg Res · journal article · DOI 10.1006/jsre.1996.0303Pharmacokinetics and metabolism of O-(chloroacetyl-carbamoyl) fumagillol (TNP-470, AGM-1470) in rhesus monkeys.
Cretton-Scott E, Placidi L, McClure H, Anderson DC, Sommadossi JP.
Cancer Chemother Pharmacol · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1007/s002800050458